Home / Companies / Start-ups / Startup offering ozempic surges with controversial ads, fake testimonials

Back

Startup offering ozempic surges with controversial ads, fake testimonials

7 min read . Updated: 04 Mar 2023, 09:47 PM IST Rolfe Winkler, The Wall Street Journal

As with many telehealth startups, NextMed’s growth has come primarily from advertising, including ads that health professionals have said are inappropriate (WSJ) — As with many telehealth startups, NextMed’s growth has come primarily from advertising, including ads that health professionals have said are inappropriate **(WSJ)**

NextMed says most of its customers are satisfied. The company was scrutinized over fake reviews and criticized by customers who had trouble getting refunds

In eight months, a startup called NextMed has emerged as a growing service among many trying to capitalize on the craze for drugs such as Ozempic, Wegovy and Mounjaro that are often prescribed for weight loss.

OPEN IN APP